Caporali, S., Alvino, E., Lacal, P. M., Ruffini, F., Levati, L., Bonmassar, L., . . . D’Atri, S. (2017). Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib. Oncotarget.
استشهاد بنمط شيكاغوCaporali, Simona, et al. "Targeting the PTTG1 Oncogene Impairs Proliferation and Invasiveness of Melanoma Cells Sensitive or With Acquired Resistance to the BRAF Inhibitor Dabrafenib." Oncotarget 2017.
MLA استشهادCaporali, Simona, et al. "Targeting the PTTG1 Oncogene Impairs Proliferation and Invasiveness of Melanoma Cells Sensitive or With Acquired Resistance to the BRAF Inhibitor Dabrafenib." Oncotarget 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.